ClassID:

21647

A61K2300/00 - page 54 - CPC Classification

Classification description:

Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups  - 

Recent Application in this class:
#15901
20080292720
2008-11-27

Cholesterol-interacting layered phyllosilicates and methods of reducing hypercholesteremia in a mammal

#15902
20080292714
2008-11-27

BONE TARGETING OF DEGRADABLE DRUG FILLED NANOPARTICLES

#15903
20080292709
2008-11-27

KITS FOR DHEA AND DHEA-SULFATE FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

#15904
20080292694
2008-11-27

Opioid agonist/antagonist combinations

#15905
20080292686
2008-11-27

Vaccine

#15906
20080292666
2008-11-27

Preparation for preventing or treating calcium deficiency conditions in mammals

#15907
20080292649
2008-11-27

Composition for improving membrane composition and functioning of cells

#15908
20080292631
2008-11-27

TREATMENT WITH ANTI-VEGF ANTIBODIES

#15909
20080292630
2008-11-27

TREATMENT WITH ANTI-VEGF ANTIBODIES

#15910
20080292626
2008-11-27

KINESIN INHIBITORS

#15911
20080292622
2008-11-27

Measurement of soluble Tweak levels for evaluation of lupus patients

#15912
20080292620
2008-11-27

PRLR-specific antibody and uses thereof

#15913
20080292613
2008-11-27

Food Supplement Based on Group B Vitamins, Trace Elements and -3 and/or 6- Fatty Acids and Use of This Food Supplement in the Simultaneous Treatment of Localized Cellulite and Slackening of the Skin

#15914
20080292612
2008-11-27

COMPOSITION CONTAINING SEVERAL BOTULIC TOXINS

#15915
20080292611
2008-11-27

NOVEL METHODS OF TREATMENT AND DELIVERY MODES

#15916
20080292609
2008-11-27

Use of Arginase in Combination with 5FU and Other Compounds for Treatment of Human Malignancies

#15917
20080292607
2008-11-27

Nutraceutical agent for attenuating the neurodegenerative process associated with Parkinson's disease

#15918
20080292597
2008-11-27

Umbilical Cord Stem Cell Composition & Method of Treating Neurological Diseases

#15919
20080292592
2008-11-27

Oncolytic Adenovirus Armed with Therapeutic Genes

#15920
20080292588
2008-11-27

1-METHYL-BENZO[1,2,4]THIADIAZINE 1-OXIDE DERIVATIVES

#15921
20080292587
2008-11-27

OXIMYL DIPEPTIDE HEPATITIS C PROTEASE INHIBITORS

#15922
20080292584
2008-11-27

METAXALONE PRODUCTS, METHOD OF MANUFACTURE, AND METHOD OF USE

#15923
20080292583
2008-11-27

Methods for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroindol-2-yl)-piperidine-2,6-dione follow by autologous stem cell transplantation

#15924
20080292562
2008-11-27

Medicaments For Inhalation Comprising Pde IV Inhibitors and Enantiomerically Pure Glycopyrrolate Salts

#15925
20080292560
2008-11-27

SILICONE IN GLYCOL PHARMACEUTICAL AND COSMETIC COMPOSITIONS WITH ACCOMMODATING AGENT

#15926
20080292559
2008-11-27

Method of treating with interferons

#15927
20080290328
2008-11-27

Photochromic material comprising a proteorhodopsin apoprotein and a retinal analog

#15928
20080287861
2008-11-20

Device and method for treatment of wounds with nitric oxide

#15929
20080287690
2008-11-20

Process for (3R, 5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid hemi calcium salt

#15930
20080287549
2008-11-20

METHODS AND MATERIALS FOR CONTROLLING RODENT POPULATIONS

#15931
20080287529
2008-11-20

CRYSTAL STRUCTURES OF SGLT2 INHIBITORS AND PROCESSES FOR PREPARING SAME

#15932
20080287528
2008-11-20

Therapeutic methods and compositions involving isoflavones

#15933
20080287515
2008-11-20

Topical compositions containing metronidazole

#15934
20080287514
2008-11-20

Topical compositions containing metronidazole

#15935
20080287513
2008-11-20

Topical compositions containing metronidazole

#15936
20080287486
2008-11-20

Prokinetic agent for bowel preparation

#15937
20080287480
2008-11-20

Therapeutic Combination Comprising a Nmda Receptors Blocker and a Narcotic Analgesic Substance

#15938
20080287476
2008-11-20

ADMINISTRATION OF DIPEPTIDYL PEPTIDASE INHIBITORS

#15939
20080287470
2008-11-20

Presentation of an antiviral pharmaceutical composition

#15940
20080287449
2008-11-20

AZA-TRIPEPTIDE HEPATITIS C SERINE PROTEASE INHIBITORS

#15941
20080287429
2008-11-20

Dissolution of Arterial Cholesterol Plaques by Pharmacologically Induced Elevation of Endogenous Bile Salts

#15942
20080287423
2008-11-20

Use of azapaullones for preventing and treating pancreatic autoimmune disorders

#15943
20080287406
2008-11-20

Compositions and methods for treating medical conditions

#15944
20080287403
2008-11-20

USE OF INHIBITORS OF THE RENIN-ANGIOTENSIN SYSTEM IN THE PREVENTION OF CARDIOVASCULAR EVENTS

#15945
20080287400
2008-11-20

Low Dosage Forms Of Risedronate Or Its Salts

#15946
20080287393
2008-11-20

External Skin Composition

#15947
20080287391
2008-11-20

Cell fusion promoter and utilization of the same

#15948
20080287390
2008-11-20

Pyrazolidinol compounds

#15949
20080287389
2008-11-20

Nucleoside analogs in combination therapy of herpes simplex infections

#15950
20080287369
2008-11-20

Compositions and Methods for Viscosupplementation

#15951
20080287366
2008-11-20

Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus

#15952
20080287365
2008-11-20

Method for proliferating natural killer cells

#15953
20080287357
2008-11-20

Conjugate Comprising P21 Protein for the Treatment of Cancer

#15954
20080286849
2008-11-20

Herbal extract having anti-virus activity and preparation of same

#15955
20080286414
2008-11-20

Drink Comprising a Combination of Fish Oil and Probiotics

#15956
20080286394
2008-11-20

NOVEL HERBAL FORMULATION AS BRAIN TONIC

#15957
20080286392
2008-11-20

Body Fat-Reducing Agent

#15958
20080286390
2008-11-20

Skin care composition

#15959
20080286388
2008-11-20

Pharmaceutical Composition and Non Dependence Coffee Comprising Edible Carboxylic Acid and/or Its Acid Salts and Coffeine

#15960
20080286384
2008-11-20

Topical Wound Care Product Containing Hyssop

#15961
20080286381
2008-11-20

Anti-tumor drug, medicament, composition, and use thereof

#15962
20080286363
2008-11-20

Pharmaceutical Compositions for the Treatment of Inflammatory and Obstructive Airways Diseases

#15963
20080286359
2008-11-20

Low Dosage Forms Of Risedronate Or Its Salts

#15964
20080286358
2008-11-20

Wake up on time dietary supplement and method of use

#15965
20080286354
2008-11-20

COMPOSITION AND THERAPIES FOR HYPERLIPIDAEMIA-ASSOCIATED DISORDERS

#15966
20080286339
2008-11-20

METHODS AND DEVICES FOR THE SUSTAINED RELEASE OF MULTIPLE DRUGS

#15967
20080286322
2008-11-20

Methods and devices for the sustained release of multiple drugs

#15968
20080286321
2008-11-20

Polymer no donor predrug nanofiber coating for medical devices and therapy

#15969
20080286315
2008-11-20

Methionine Enkephalin as an Adjuvant for Vaccine Immunizations

#15970
20080286301
2008-11-20

Treatment of diabetes

#15971
20080286290
2008-11-20

Anti-CD14 antibody fusion protein

#15972
20080286289
2008-11-20

Use of B Cell Expansion Agents in Generating Antibodies

#15973
20080286282
2008-11-20

Novel Use of Sulfonamide Compound in Combination with Angiogenesis Inhibitor

#15974
20080286258
2008-11-20

Bifeprunox mesylate maintenance dose compositions and methods for using the same

#15975
20080286254
2008-11-20

Composition comprising licorice polyphenol

#15976
20080286251
2008-11-20

Compositions and Methods for the Enhancement of Chemotherapy with Microbial Cytotoxins

#15977
20080286242
2008-11-20

AUGMENTATION AND REPAIR OF SPINCTER DEFECTS WITH CELLS INCLUDING MESENCHYMAL CELLS

#15978
20080286239
2008-11-20

COMBINED TUMOR SUPPRESSOR GENE THERAPY AND CHEMOTHERAPY IN THE TREATMENT OF NEOPLASMS

#15979
20080286237
2008-11-20

Systemic Treatment of Metastatic and/or Systemically-Disseminated Cancers using GM-CSF-Expressing Poxviruses

#15980
20080286234
2008-11-20

Method for treating demyelinating diseases

#15981
20080286233
2008-11-20

PIPERIZINYL MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS

#15982
20080286232
2008-11-20

Methods for treating sarcoma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione or 4-(amino)-2-(2,6 dioxo(3-piperidyl))-isoindoline-1,3-dione

#15983
20080286227
2008-11-20

Use of Il-17F for the Treatment and/or Prevention of Neurologic Diseases

#15984
20080286223
2008-11-20

Compositions Having a High Antiviral and Antibacterial Efficacy

#15985
20080286211
2008-11-20

Using mucin glycoproteins in combination with therapeutic agents to treat epithelial lesions and disorders of impaired mucin function

#15986
20080282602
2008-11-20

Therapeutic Skin Treatment Composition and Method

#15987
20080281236
2008-11-13

Devices and methodologies useful in body aesthetics

#15988
20080281082
2008-11-13

HUMANIZED ANTIBODIES THAT RECOGNIZE BETA AMYLOID PEPTIDE

#15989
20080281081
2008-11-13

Polyvinylpyrrolidone cryoprecipitate extraction of clotting factors

#15990
20080280980
2008-11-13

Treatment and prevention of bone loss using resolvins

#15991
20080280975
2008-11-13

Methods of preventing the serotonin syndrome and compositions for use thereof

#15992
20080280968
2008-11-13

METHODS OF USING [3.2.0] HETEROCYCLIC COMPOUNDS AND ANALOGS THEREOF FOR TREATING INFECTIOUS DISEASES

#15993
20080280939
2008-11-13

Combination of Organic Compounds

#15994
20080280932
2008-11-13

COMPOSITIONS AND METHODS FOR TREATING VASCULAR, AUTOIMMUNE, AND INFLAMMATORY DISEASES

#15995
20080280867
2008-11-13

COMBINATION THERAPY WITH PARP INHIBITORS

#15996
20080280863
2008-11-13

COMPOSITIONS FOR THE TREATMENT OF INFLAMMATORY DISORDERS

#15997
20080280861
2008-11-13

Method of Female Contraception and a Kit For Use Therein

#15998
20080280852
2008-11-13

Composition containing fermentable polysaccharides

#15999
20080280850
2008-11-13

Methods and Compositions for Treating Flaviviruses, Pestiviruses and Hepacivirus

#16000
20080280849
2008-11-13

Synergic Combinations Comprising a Quinoline Compound and Other Hiv Infection Therapeutic Agents

#16001
20080280846
2008-11-13

2′,3′-dideoxynucleoside analogues for the treatment or prevention of infections

#16002
20080280840
2008-11-13

MELOXICAM FOR THE TREATMENT OF RESPIRATORY DISEASES IN PIGS

#16003
20080280835
2008-11-13

Novel Use of Peptide Compounds For Treating Muscle Pain

#16004
20080280817
2008-11-13

MODIFIED AMINO ACID FOR THE INHIBITION OF PLATELET AGGREGATION

#16005
20080280816
2008-11-13

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR HEALING WOUNDS

#16006
20080279966
2008-11-13

Branched-chain amino acid composition for improving skeletal muscle protein metabolism

#16007
20080279965
2008-11-13

Treatment of injury to the brain by inhibition of acid sensing ion channels

#16008
20080279963
2008-11-13

PHYSIOLOGICALLY BALANCED, IONIZED, ACIDIC SOLUTION AND METHODOLOGY FOR USE IN WOUND HEALING

#16009
20080279961
2008-11-13

TELOMERE TARGETING AGENTS AS STEM CELLS DIRECTED TREATMENTS

#16010
20080279948
2008-11-13

Treatment of Asthma and Copd Using Triple-Combination Therapy

#16011
20080279946
2008-11-13

Gold nanoparticles for selective IR heating

#16012
20080279939
2008-11-13

EXTRACELLULAR MATRIX COMPOSITIONS FOR TISSUE REGENERATION

#16013
20080279933
2008-11-13

Flurbiprofen and muscle relaxant combinations

#16014
20080279923
2008-11-13

Use of Microtubule Stabilizing Compounds for the Treatment of Lesions of Cns Axons

#16015
20080279913
2008-11-13

Use of salicylaldehyde isonicotinoyl hydrazone (SIH) for protection against retinal disease

#16016
20080279902
2008-11-13

Delivery system and method to deliver homeopathic complexes comprising homeopathic colored pigment products for cosmetic use

#16017
20080279885
2008-11-13

Topical formulation containing latex of fraction thereof, and cosmetic treatment method

#16018
20080279884
2008-11-13

Ingestible Plaque Eliminator for Animals

#16019
20080279883
2008-11-13

Ingestible Malodor Eliminator for Animals

#16020
20080279882
2008-11-13

Phyto-nutraceutical synergistic composition for hyperlipedemic condition

#16021
20080279865
2008-11-13

Therapy of Prostate Cancer With Ctla-4 Antibodies and Hormonal Therapy

#16022
20080279864
2008-11-13

High throughput screen utilizing newly discovered intramolecular neuronal calcium channel interactions to discover new analgesics

#16023
20080279862
2008-11-13

Combination therapy with co-stimulatory factors

#16024
20080279860
2008-11-13

Treatment With Anti-VEGF Antibodies

#16025
20080279850
2008-11-13

B-Cell Reduction Using CD37-Specific and CD20-Specific Binding Molecules

#16026
20080279848
2008-11-13

Methods of treating lupus using CD4 antibodies

#16027
20080279845
2008-11-13

COMBINATION THERAPY WITH A COMPOUND ACTING AS A PLATELET ADP RECEPTOR INHIBITOR

#16028
20080279839
2008-11-13

Composition with a fungal (yeast) lipase and method for treating lipid malabsorption in cystic fibrosis as well as people suffering from pancreatic lipase insufficiency

#16029
20080279837
2008-11-13

Composition for maintaining androgen and androgen-like uptake potential by cells

#16030
20080279832
2008-11-13

OSTEOGENIC DIFFERENTIATION OF PREOSTEOBLASTIC CELLS

#16031
20080279830
2008-11-13

SPONGY EPITHELIAL CELL SCAFFOLD FOR VASCULARIZING WOUNDS

#16032
20080279821
2008-11-13

ARYLPIPERIDINYL AND ARYLPYRROLIDINYL MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS

#16033
20080279820
2008-11-13

Compositions and Methods for Treating Burns

#16034
20080279819
2008-11-13

Combinations Therapy for Treatment of Demyelinating Conditions

#16035
20080279818
2008-11-13

Combination Preparation of a Biological Response Modifier and an Anticancer Agent and Uses Thereof

#16036
20080279817
2008-11-13

Treatment of Autoimmune Diseases and Allograft Rejection with IL-21

#16037
20080279814
2008-11-13

METHODS OF TREATING NEUROLOGICAL CONDITIONS WITH HEMATOPOEITIC GROWTH FACTORS

#16038
20080279813
2008-11-13

Cd4+ Cd25+ T-cells activated to a specific antigen

#16039
20080279812
2008-11-13

Disease Prevention and Vaccination Prior to Thymic Reactivation

#16040
20080279789
2008-11-13

Combination Of Dehydroepiandrosterone Or Dehydroepiandrosterone-Sulfate With An Anticholinergic Bronchodilator For Treatment Of Asthma Or Chronic Obstructive Pulmonary Disease

#16041
20080279786
2008-11-13

Method for extending lifespan delaying the onset of age-related disease

#16042
20080276935
2008-11-13

TREATMENT OF ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH ANTI-PROLIFERATE AND ANTI-INFLAMMATORY DRUGS

#16043
20080275272
2008-11-06

AMINE COMPOUNDS AND INHIBITING NEUROTRANSMITTER REUPTAKE

#16044
20080275126
2008-11-06

ALIPHATIC ACID-CONTAINING N-HALOGENATED AMINO ACID FORMULATIONS

#16045
20080275125
2008-11-06

Combination Composition

#16046
20080275123
2008-11-06

N-HALOGENATED AMINO ACID FORMULATIONS

#16047
20080275122
2008-11-06

N-HALOGENATED AMINO ACID FORMULATIONS WITH ANTI-INFLAMMATORY COMPOUNDS

#16048
20080275121
2008-11-06

N-HALOGENATED AMINO ACID FORMULATIONS AND METHODS FOR CLEANING AND DISINFECTION

#16049
20080275120
2008-11-06

LEUCINE RICH COMPOSITION

#16050
20080275110
2008-11-06

Sesamin/Episesamin Compositions

#16051
20080275107
2008-11-06

TOPICAL FORMULATIONS AND METHODS FOR ELIMINATION AND PROPHYLAXIS OF SUSCEPTIBLE AND TREATMENT RESISTANT STRAINS OF HEAD LICE WITH MULTIPLE MODES OF ACTION

#16052
20080275095
2008-11-06

Combination of Prostaglandin E2 Receptor Antagonists and Renin-Angiotensin System Inhibitors for Treating Renal Diseases

#16053
20080275089
2008-11-06

Compositions and methods to treat gastrointestinal disorders

#16054
20080275080
2008-11-06

Methods for treating lower urinary tract disorders using alpha2delta subunit channel modulators with smooth muscle modulators

#16055
20080275071
2008-11-06

Radiotherapy Enhancer

#16056
20080275020
2008-11-06

PHARMACEUTICAL FORMULATION

#16057
20080275015
2008-11-06

Formulation and Method for Treating Interstitial Cystitis and Related Bladder Conditions

#16058
20080275010
2008-11-06

COMPOSITIONS AND METHODS TO PREVENT TOXICITY INDUCED BY NONSTEROIDAL ANTIINFLAMMATORY DRUGS

#16059
20080275009
2008-11-06

ORAL ADMINISTRATION OF N-(2-CHLORO-6-METHYLPHENYL)-2-[[6-[4-(2-HYDROXYETHYL)-1-PIPERAZINYL]-2-METHYL-4-PYRIMIDINYL]AMINO]-1,3-THIAZOLE-5-CARBOXAMIDE AND SALTS THEREOF

#16060
20080275007
2008-11-06

CHARGED PHOSPHOLIPID COMPOSITIONS AND METHODS FOR THEIR USE

#16061
20080274983
2008-11-06

Amelioration of the development of cataracts and other ophthalmic diseases

#16062
20080274946
2008-11-06

Composition for restoration of age related tissue loss in the face or selected areas of the body

#16063
20080274546
2008-11-06

ARTIFICIAL PHYSIOLOGICAL SALT SOLUTION AND MANUFACTURING METHOD FOR SAME

#16064
20080274215
2008-11-06

COMPOSITION FOR TREATMENT OF COLD AND FLU

#16065
20080274212
2008-11-06

Herbal extract for renal disorders

#16066
20080274211
2008-11-06

Methods and compositions for controlling microorganism populations in the digestive system of animals

#16067
20080274209
2008-11-06

METHODS OF TREATING INFLAMMATION

#16068
20080274208
2008-11-06

Water treatment containing DBNPA for use in sanitizing recreational water

#16069
20080274205
2008-11-06

ENA mineral bioactive solution, manufacturing method thereof and its application for the osteoporosis prevention

#16070
20080274203
2008-11-06

Bioeffective krill oil compositions

#16071
20080274189
2008-11-06

Organic Compounds Comprising a Glycopyrr Onium Salt

#16072
20080274165
2008-11-06

Wound healing compositions containing keratin biomaterials

#16073
20080274159
2008-11-06

Drug formulations for coating medical devices

#16074
20080274157
2008-11-06

Cartilage implant plug with fibrin glue and method for implantation

#16075
20080274153
2008-11-06

Use of Emu Oil and its various fractions as a carrier for antifungal, antibacterial, and antiviral medications & preparations

#16076
20080274121
2008-11-06

Inhibition of Angiogenesis by Mithramycin

#16077
20080274120
2008-11-06

Histone deacetylase (HDAC) inhibitors (PXD101) for the treatment of cancer alone or in combination with chemotherapeutic agent

#16078
20080274119
2008-11-06

Use of opioid antagonists to attenuate endothelial cell proliferation and migration

#16079
20080274107
2008-11-06

Tyrosine kinase inhibitors

#16080
20080274094
2008-11-06

Molecular Complex Comprising Arbutine, Ascorbic Acid, Oleuropeina or Its Derivatives Thereof and Related Uses In Medical Field

#16081
20080274082
2008-11-06

OXIMYL HYDROXYAMIC ANALOGS AS HEPATITIS C VIRUS PROTEASE INHIBITOR

#16082
20080274078
2008-11-06

NOVEL USES

#16083
20080274077
2008-11-06

Method for Treating Neurological Disorders

#16084
20080269347
2008-10-30

EPINEPHRINE FORMULATIONS

#16085
20080269339
2008-10-30

COMBINED USE OF EGF PATHWAY INHIBITORS AND DIFFERENTIATION PROMOTING COMPOUNDS

#16086
20080269331
2008-10-30

Use of polyunsaturated fatty acids for the primary prevention of major cardiovascular events

#16087
20080269327
2008-10-30

Magnesium compositions and uses thereof for cognitive function

#16088
20080269321
2008-10-30

Therapeutic Combinations for the Treatment or Prevention of Depression

#16089
20080269311
2008-10-30

Combination of Dpp-Iv Inhibitors and Compounds Modulating 5-Ht3 and/or 5-Ht4 Receptors

#16090
20080269310
2008-10-30

Synergistic Combinations

#16091
20080269307
2008-10-30

Use of the acetyl L-carnitine in association with the biotin for the treatment of patients with type 2 insulin-resistant diabetes mellitus

#16092
20080269273
2008-10-30

TREATMENT METHOD

#16093
20080269261
2008-10-30

Combination of Zd6474 and Pemetrexed

#16094
20080269259
2008-10-30

Regulation of Autophagy and Cell Survival

#16095
20080269236
2008-10-30

1,2,4 oxadiazole compounds and methods of use thereof

#16096
20080269203
2008-10-30

Benzodiazepine compositions for treating epidermal hyperplasia and related disorders

#16097
20080269189
2008-10-30

Methods for avoiding edema in the treatment or prevention of PPARγ-responsive diseases, including cancer

#16098
20080269182
2008-10-30

Method of treating cancers with SAHA and Pemetrexed

#16099
20080269179
2008-10-30

Use of Megestrol Acetate for the Treatment of Obstructive Pulmonary Diseases

#16100
20080269167
2008-10-30

Preparation Comprising Iron(III) Complex Compounds And Redox-Active Substance(s)

#16101
20080269162
2008-10-30

Novel Medicaments for Anti-Retroviral Treatments

#16102
20080269161
2008-10-30

Compositions and Methods Relating to Mitochondrial Hyperpolarization in Neurological Disease

#16103
20080269117
2008-10-30

Preparation for use of aspartate for regulating glucose levels in blood

#16104
20080269111
2008-10-30

Method of treating dyslipidemic disorder

#16105
20080268102
2008-10-30

Method of supplementing an edible aqueous liquid composition with two or more mineral salts

#16106
20080268092
2008-10-30

Capsaicin Nutritional Supplement

#16107
20080268075
2008-10-30

Herbal composition weight management

#16108
20080268068
2008-10-30

Sparc Promoter Mutations Associated with Drug Resistance, and Methods, Oligonucleotides, Cells and Arrays Associated Therewith

#16109
20080268067
2008-10-30

Methods and Compositions for Treating Thalamocortical Dysrhythmia

#16110
20080268066
2008-10-30

Synergistic Formulation for Preventing and/or Treating Diabetes

#16111
20080268064
2008-10-30

METHOD FOR TREATING CARTILAGE DEFECTS

#16112
20080268049
2008-10-30

Stable Solid Dosage Forms of Amlodipine and Benazepril

#16113
20080268048
2008-10-30

PHARMACEUTICAL COMPOSITION FOR CONTRACEPTION AND FOR REDUCING THE RISK OF CONGENITAL ABNORMALITIES

#16114
20080268046
2008-10-30

Formulations with Controlled Release of Active Ingredient

#16115
20080268043
2008-10-30

Controlled Release Compositions Comprising an Antipsychotic Agent

#16116
20080268042
2008-10-30

OMEGA 3 FATTY ACID FORMULATIONS

#16117
20080268041
2008-10-30

COMBINATION OF PROGESTERONE-RECEPTOR ANTAGONIST TOGETHER WITH NONE-STEROIDAL ANTIESTROGEN FOR USE IN BRCA MEDIATED DISEASES

#16118
20080268038
2008-10-30

Compositions and Approaches for Increasing Diet Induced Thermogenesis, Inducing Weight Loss and Maintaining Muscle Mass and Strength

#16119
20080268024
2008-10-30

Compositions for Oral and/or Topical Administration

#16120
20080268012
2008-10-30

Activating extraction of demineralized bone matrix

#16121
20080268006
2008-10-30

Probiotic strains for improved vaginal health

#16122
20080267994
2008-10-30

Induction of dendritic cell development with macrophage-colony stimulating factor (M-CSF)

#16123
20080267977
2008-10-30

Combined immunological agent and sensitizing agent for the treatment of cancer

#16124
20080267968
2008-10-30

TREATMENT WITH ANTI-VEGF ANTIBODIES

#16125
20080267964
2008-10-30

Synergistic Effect of Tgf-Beta Blockade and Immunogenic Agents on Tumors

#16126
20080267960
2008-10-30

Methods of treating neoplastic, autoimmune and inflammatory diseases

#16127
20080267957
2008-10-30

Combination cancer therapy

#16128
20080267939
2008-10-30

SYNERGISTIC ANTI-HYPERTENSIVE PHYTO-NUTRACEUTICAL COMPOSITION

#16129
20080267938
2008-10-30

CARDIAC PHYTO-NUTRACEUTICAL SYNERGISTIC COMPOSITION

#16130
20080267935
2008-10-30

AraC in combination with a cytokine-secreting cell and methods of use thereof

#16131
20080267927
2008-10-30

Methods for improving cell therapy and tissue regeneration in patients with cardiovascular diseases by means of shockwaves

#16132
20080267923
2008-10-30

HAIR UNDIFFERENTIATED CELLS

#16133
20080267918
2008-10-30

Quinoxalinyl dipeptide hepatitis C virus inhibitors

#16134
20080267917
2008-10-30

N-FUNCTIONALIZED AMIDES AS HEPATITIS C SERINE PROTEASE INHIBITORS

#16135
20080267916
2008-10-30

Cyclic P3 tripeptide hepatitis C serine protease inhibitors

#16136
20080267915
2008-10-30

Hcv Ns3-Ns4a Protease Inhibition

#16137
20080267905
2008-10-30

Methods and Compositions Using Selective Cytokine Inhibitory Drugs for Treatment and Management of Cancers and Other Diseases

#16138
20080267886
2008-10-30

Combinations of Glycopyrrolate and Beta2 Adrenoceptor Agonists

#16139
20080267862
2008-10-30

METHOD OF TREATING CANCER

#16140
20080262415
2008-10-23

ENHANCED WOUND HEALING

#16141
20080262411
2008-10-23

DYNAMIC NERVE STIMULATION IN COMBINATION WITH OTHER EATING DISORDER TREATMENT MODALITIES

#16142
20080262094
2008-10-23

Treatment of Comorbid Premature Ejaculation and Erectile Dysfunction

#16143
20080262091
2008-10-23

Infiltration of capsaicin into surgical sites and open wounds

#16144
20080262081
2008-10-23

Novel Use of Nutraceutical Compositions Comprising Resveratrol

#16145
20080262077
2008-10-23

PHARMACEUTICAL FORMULATIONS CONTAINING LIPOIC ACID DERIVATIVES

#16146
20080262072
2008-10-23

Compositions And Kits Comprising A Melatonin Component And A Flavanol Component

#16147
20080262059
2008-10-23

Methods of treatment and pharmaceutical composition

#16148
20080262047
2008-10-23

Ppar-Gamma Agonists for Improvement of Cognitive Function in Apoe4 Negative Patients

#16149
20080262003
2008-10-23

Methods for treating neoplasia with combination of chemotherapeutic agents and radiation

#16150
20080262002
2008-10-23

Use of S-adenosylmethionine, vitamin E, and vitamin C for the treatment of oxidative liver injury and insulin resistance

#16151
20080261991
2008-10-23

Reducing Side Effects of Tramadol

#16152
20080261958
2008-10-23

Combination of Organic Compounds

#16153
20080261955
2008-10-23

Use of Pharmaceutical Compositions of Lofepramine for the Treatment of Adhd, Cfs, Fm and Depression

#16154
20080261942
2008-10-23

COMBINATIONS OF BILE ACID SEQUESTRANT(S) AND STEROL ABSORPTION INHIBITOR(S) AND TREATMENTS FOR VASCULAR INDICATIONS

#16155
20080261934
2008-10-23

Dosage form for hormonal contraception

#16156
20080261933
2008-10-23

COMBINATION OF PROGESTERONE-RECEPTOR ANTAGONIST TOGETHER WITH A LUTEIN-HORMONE-RELEASING HORMONE AGONIST AND ANTAGONIST FOR USE IN BRCA MEDIATED DISEASES

#16157
20080261932
2008-10-23

METHODS AND COMPOSITIONS FOR THE PREVENTION AND/OR TREATMENT OF AN EXACERBATION OF ASTHMA

#16158
20080261930
2008-10-23

Enhancement of activity and/or duration of action of selected anti-inflammatory steroids for topical or other local application

#16159
20080261928
2008-10-23

Method of treating human preeclampsia employing resibufagenin

#16160
20080261927
2008-10-23

Stable Aqueous Suspension

#16161
20080261922
2008-10-23

Pharmacological treatments for sleep disorders (apnoe) with prostanoid receptor antagonists

#16162
20080261897
2008-10-23

Formulation Containing a Polyphenol-Containing Composition and Isomaltulose

#16163
20080261894
2008-10-23

Combination Therapy with Glatiramer Acetate and Rasagiline for the Treatment of Multiple Sclerosis

#16164
20080261893
2008-10-23

TOPICAL CORNEAL ANALGESIA USING NEUROTENSIN RECEPTOR AGONISTS AND SYNERGISTIC NEUROTENSIN COMBINATIONS WITHOUT DELAYING WOUND HEALING

#16165
20080261891
2008-10-23

COMPOSITIONS AND METHODS FOR USING SYRINGOPEPTIN 25A AND RHAMNOLIPIDS

#16166
20080261890
2008-10-23

Use of neurotransmitters and neuropeptides for the treatment of dry eye diseases and related conditions

#16167
20080261886
2008-10-23

Single-dose administration of Factor VIIa

#16168
20080261884
2008-10-23

Lung volume reduction therapy using crosslinked biopolymers

#16169
20080261879
2008-10-23

Method of inducing and maintaining neuronal cells

#16170
20080261866
2008-10-23

Compositions Comprising Glycosaminoglycan and Nonsteroidal Anti-Inflammatory Drug

#16171
20080261864
2008-10-23

Combination of nateglinide or repaglinide with at least one further antidiabetic compound

#16172
20080260881
2008-10-23

Blue-green algae composition

#16173
20080260877
2008-10-23

Plant extracts and compositions for reducing blood lipid levels

#16174
20080260876
2008-10-23

Garlic Extract Compositions, Uses And Preparations Thereof

#16175
20080260875
2008-10-23

Skin care compositions and methods

#16176
20080260868
2008-10-23

Folate based composition for neurological and cognitive applications

#16177
20080260859
2008-10-23

Composition Containing Omega-3 Fatty Acids and Omega-6 Fatty Acids

#16178
20080260858
2008-10-23

Universal Procoagulant

#16179
20080260856
2008-10-23

Topical composition containing sacred water

#16180
20080260845
2008-10-23

MULTIPLE ACTIVE DRUG RESIN CONJUGATE

#16181
20080260837
2008-10-23

Physically stable aqueous suspensions of active pharmaceuticals

#16182
20080260825
2008-10-23

Methods and compositions for reduction of side effects of therapeutic treatments

#16183
20080260820
2008-10-23

Oral dosage formulations of protease-resistant polypeptides

#16184
20080260817
2008-10-23

Compositions for the Treatment of Inflammation and Pain Using a Combination of a Cox-2 Selective Inhibitor and a Ltb4 Receptor Antagonist

#16185
20080260791
2008-10-23

Injectable capsaicin

#16186
20080260790
2008-10-23

Plasmid Enhancement Agent for High Intensity Focused Ultrasound Treatment and Use Thereof

#16187
20080260787
2008-10-23

Use of Collagen in Combination With Oxygen- and Ozone-Releasing Perfluorocarbons For the Preparation of a Medicament For the Treatment of Skin Lesions

#16188
20080260784
2008-10-23

Compositions and methods for modulating an immune response

#16189
20080260771
2008-10-23

PROSTATE DISORDER(S) PHYTO-NUTRACEUTICAL SYNERGISTIC COMPOSITION

#16190
20080260756
2008-10-23

Peptide inhibitors of IASPP

#16191
20080260745
2008-10-23

Targeted identification of immunogenic peptides

#16192
20080260737
2008-10-23

Combination of BLyS and/or APRIL inhibition and immunosuppressants for treatment of autoimmune disease

#16193
20080260728
2008-10-23

Treatment of Severe Multiple Sclerosis

#16194
20080260714
2008-10-23

Fibrin Compositions Containing Strontium Compounds

#16195
20080260710
2008-10-23

Method for suppressing surgical site infection and column to be used for the method

#16196
20080260708
2008-10-23

METHODS AND RELATED SYSTEMS AND FORMULATIONS TO NORMALIZE AND IMPROVE HUMAN BODY CHEMISTRY AND HEALING ABILITY

#16197
20080260704
2008-10-23

Combination treatment of cardiovascular disease

#16198
20080260703
2008-10-23

Treatment of Insulin Resistance and Diabetes

#16199
20080260695
2008-10-23

Composition for prevention and/or treatment of cancer

#16200
20080260694
2008-10-23

Multipotential Expanded Mesenchymal Precursor Cell Progeny (Memp) and Uses Thereof